Tech Company Financing Transactions
Trimtech Therapeutics Funding Round
Trimtech Therapeutics closed a $31 million Seed funding round on 3/5/2025. Investors included Cambridge Innovation Capital, Dementia Discovery Fund and Cambridge Enterprise.
Transaction Overview
Company Name
Announced On
3/5/2025
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to develop its pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge B
Cambridge, CB2 0AW
UK
Cambridge, CB2 0AW
UK
Phone
Website
Email Address
Not Recorded
Overview
At TRIMTECH Therapeutics our mission is to create novel, highly differentiated, orally active small molecule degraders of protein aggregates that will combat major neurodegenerative and inflammatory disorders with a significant medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicki Thompson
Browse more venture capital transactions:
Prev: 3/5/2025: Supergut venture capital transaction
Next: 3/5/2025: Epirus venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs